Novel Nanoarray SARS-CoV-2 Vaccine Helps Protect Immunocompromised

Novel COVID-19 research on a modular vaccine platform has been posted to the Research Square / Scientific Reports preprint* server. The researchers present a peptide nanoarray scaffold vaccine that may prove useful for infection control of the severe acute respiratory coronavirus 2 (SARS-CoV-2).